Search

Your search keyword '"Bridoux, Franck"' showing total 40 results

Search Constraints

Start Over You searched for: Author "Bridoux, Franck" Remove constraint Author: "Bridoux, Franck"
40 results on '"Bridoux, Franck"'

Search Results

1. Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients

2. Mass spectrometry-based proteomics in clinical practice amyloid typing: state-of-the-art from a French nationwide cohort

5. Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients

6. Spectrum of Mutations in Gitelman Syndrome

8. Lower respiratory tract amyloidosis: Presentation, survival and prognostic factors. A multicenter consecutive case series

9. Carfilzomib Weekly 20/56mg/m², Lenalidomide and Dexamethasone for Early Relapsed Refractory Multiple Myeloma

10. Chronic HCV Infection and Autologous Stem Cell Transplantation for Multiple Myeloma

12. Adverse events associated with currently used medical treatments for cystinuria and treatment goals: results from a series of 442 patients in France.

13. How I treat monoclonal gammopathy of renal significance (MGRS)

14. Very low residual concentrations of rituximab long after infusion still induce positive B-cell complement-dependent cytotoxicity-crossmatch

15. Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant

16. Al amyloidosis

17. The pathogenesis and diagnosis of acute kidney injury in multiple myeloma

18. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress]

19. [Current treatment of AL amyloidosis]

20. Renal improvement in myeloma with plasma exchange

21. Adult Fanconi Syndrome Secondary to Light Chain Gammopathy

22. CKD and Its Risk Factors among Patients with Cystinuria

23. Erratum to “Very low residual concentrations of rituximab long after infusion still induce positive B-cell complement-dependent cytotoxicity-crossmatch” [Hum. Immunol. 74 (2013) 1616–1618]

24. [Disseminated arterial occlusions revealing bilateral venous thrombosis with paradoxical embolisms]

25. Atteintes uro-néphrologiques au cours des amyloses

26. [Quinine-induced renal bilateral cortical necrosis]

27. Renal disease in cryoglobulinemic vasculitis

28. [Effects of smoking on the thyroid gland, digestive system, kidney and bone]

29. Atteinte glomérulaire au cours des dysglobulinémies et des cryoglobulinémies

30. The Alarmin Concept Applied to Human Renal Transplantation: Evidence for a Differential Implication of HMGB1 and IL-33

31. Upregulation of c-mip is closely related to podocyte dysfunction in membranous nephropathy

32. Effectiveness of Second Line Treatment in AL Amyloidosis Patients Refractory to M-Dex.

33. HGF Measurement in AL Amyloidosis.

34. Lenalidomide in Combination with Melphalan and Dexamethasone in Patients with Newly-Diagnosed Light-Chain (AL)-Amyloidosis: a Multicenter Phase I/II Dose Escalation Study.

35. A Multicenter Phase I/II Dose Escalation Study of Lenalidomide in Combination with Melphalan and Dexamethasone in Subjects with Newly-Diagnosed Light-Chain (AL)-Amyloidosis.

37. Light and heavy chain deposition disease associated with CH1 deletion.

38. Pomalidomide 3rd Line Versus 4thLine for RRMM

39. French practical guidelines for the diagnosis and management of AA amyloidosis.

40. Very low residual concentrations of rituximab long after infusion still induce positive B-cell complement-dependent cytotoxicity-crossmatch.

Catalog

Books, media, physical & digital resources